Multiscale simulations of biological membranes: the challenge to understand biological phenomena in a living substance

G Enkavi, M Javanainen, W Kulig, T Róg… - Chemical …, 2019 - ACS Publications
Biological membranes are tricky to investigate. They are complex in terms of molecular
composition and structure, functional over a wide range of time scales, and characterized by …

Virus–receptor interactions: the key to cellular invasion

MS Maginnis - Journal of molecular biology, 2018 - Elsevier
Virus–receptor interactions play a key regulatory role in viral host range, tissue tropism, and
viral pathogenesis. Viruses utilize elegant strategies to attach to one or multiple receptors …

Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2

L Nguyen, KA McCord, DT Bui, KM Bouwman… - Nature Chemical …, 2022 - nature.com
Emerging evidence suggests that host glycans influence severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. Here, we reveal that the receptor-binding domain …

Virus recognition of glycan receptors

AJ Thompson, RP de Vries, JC Paulson - Current Opinion in Virology, 2019 - Elsevier
Highlights•Most mammalian virus families use cell-surface glycans as receptors.•Glycan
receptors are diverse in structure and distribution, giving rise to species and tissue …

JC Virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor

BA O'Hara, J Morris-Love, GV Gee, SA Haley… - PLoS …, 2020 - journals.plos.org
The human polyomavirus, JCPyV, is the causative agent of progressive multifocal
leukoencephalopathy (PML) in immunosuppressed and immunomodulated patients. Initial …

JC polyomavirus uses extracellular vesicles to infect target cells

J Morris-Love, GV Gee, BA O'Hara, B Assetta… - MBio, 2019 - Am Soc Microbiol
The endemic human JC polyomavirus (JCPyV) causes progressive multifocal
leukoencephalopathy in immune-suppressed patients. The mechanisms of virus infection in …

Fifty years of JC polyomavirus: a brief overview and remaining questions

AL Atkinson, WJ Atwood - Viruses, 2020 - mdpi.com
In the fifty years since the discovery of JC polyomavirus (JCPyV), the body of research
representing our collective knowledge on this virus has grown substantially. As the …

The biology of JC polyomavirus

B Assetta, WJ Atwood - Biological chemistry, 2017 - degruyter.com
JC polyomavirus (JCPyV) is the causative agent of a fatal central nervous system
demyelinating disease known as progressive multifocal leukoencephalopathy (PML). PML …

Understanding progressive multifocal leukoencephalopathy risk in multiple sclerosis patients treated with immunomodulatory therapies: a bird's eye view

EA Mills, Y Mao-Draayer - Frontiers in Immunology, 2018 - frontiersin.org
The increased use of newer potent immunomodulatory therapies for multiple sclerosis (MS),
including natalizumab, fingolimod, and dimethyl fumarate, has expanded the patient …

Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector

CN Chao, YH Yang, MS Wu, MC Chou, CY Fang… - Scientific Reports, 2018 - nature.com
Glioblastoma multiforme (GBM), the most common malignant brain tumor, has a short period
of survival even with recent multimodality treatment. The neurotropic JC polyomavirus …